FDA Approves New Frontline Regimen for Aggressive ALL

(MedPage Today) -- The FDA granted accelerated approval to ponatinib (Iclusig) in combination with chemotherapy for Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) in previously untreated adults, the agency announced this...
Source: MedPage Today Public Health - Category: American Health Source Type: news